Joanne E. Mortimer
Impact in
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer survivorship and care
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 110
- HER2/EGFR in Cancer Research 32
- Cancer Treatment and Pharmacology 22
- Cancer Risks and Factors 15
- Cancer Immunotherapy and Biomarkers 11
- Cancer survivorship and care 10
-
- Breast Cancer Treatment Studies 26
- Co-authors
- Farrokh Dehdashti (6 shared papers)Christina Marie Dieli-Conwright (18 shared papers)John A. Katzenellenbogen (4 shared papers)Barry Alan Siegel (4 shared papers)Kyuwan Lee (12 shared papers)Jaffer A. Ajani (2 shared papers)Norman C. Estes (2 shared papers)Daniel G. Haller (2 shared papers)
- Journals
- Journal of Clinical Oncology (19 papers)Journal of the National Comprehensive Cancer Network (15 papers)Cancer (15 papers)The Oncologist (12 papers)Breast Cancer Research and Treatment (12 papers)
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Joanne E. Mortimer
225 papers receiving 13.9k citations
Joanne E. Mortimer's Hit Papers
Peers
Comparison fields: 5 of 147
- Oncology 4.8k
- Cancer Research 2.5k
- Otorhinolaryngology 418
- Pulmonary and Respiratory Medicine 2.8k
- Radiology, Nuclear Medicine and Imaging 1.8k
Countries citing papers authored by Joanne E. Mortimer
This map shows the geographic impact of Joanne E. Mortimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne E. Mortimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne E. Mortimer more than expected).
Fields of papers citing papers by Joanne E. Mortimer
This network shows the impact of papers produced by Joanne E. Mortimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne E. Mortimer. The network helps show where Joanne E. Mortimer may publish in the future.
Co-authors
The 25 scholars most cited alongside Joanne E. Mortimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 232 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2020 | 1325 |
| 2 | Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer Hit paper breakdown → | 1998 | 1083 |
| 3 | Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2022 | 674 |
| 4 | A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. Hit paper breakdown → | 1992 | 521 |
| 5 | Long-Term Results of RTOG Trial 8911 (USA Intergroup 113): A Random Assignment Trial Comparison of Chemotherapy Followed by Surgery Compared With Surgery Alone for Esophageal Cancer Hit paper breakdown → | 2007 | 435 |
| 6 | 1995 | 366 | |
| 7 | 2001 | 332 | |
| 8 | NCCN Guidelines® Insights: Breast Cancer, Version 4.2023 Hit paper breakdown → | 2023 | 317 |
| 9 | 2019 | 310 | |
| 10 | Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2024 | 298 |
| 11 | 2018 | 290 | |
| 12 | 2011 | 287 | |
| 13 | 2019 | 269 | |
| 14 | Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. | 1995 | 247 |
| 15 | 1999 | 241 | |
| 16 | 2004 | 240 | |
| 17 | NCCN Guidelines® Insights: Breast Cancer, Version 4.2021 Hit paper breakdown → | 2021 | 239 |
| 18 | 2010 | 236 | |
| 19 | 2018 | 228 | |
| 20 | 1987 | 214 |
About Joanne E. Mortimer
Joanne E. Mortimer is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 232 papers that have together received 14.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (32 papers), Breast Cancer Treatment Studies (26 papers), Cancer Treatment and Pharmacology (22 papers), Advanced Breast Cancer Therapies (18 papers), Cancer Risks and Factors (15 papers), Cancer Immunotherapy and Biomarkers (11 papers), Cancer survivorship and care (10 papers) and Cancer-related cognitive impairment studies (10 papers). The work is most often cited by research in Oncology (4.8k citations), Cancer Research (2.5k citations), Otorhinolaryngology (418 citations), Pulmonary and Respiratory Medicine (2.8k citations) and Radiology, Nuclear Medicine and Imaging (1.8k citations). Joanne E. Mortimer has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Farrokh Dehdashti, Christina Marie Dieli-Conwright, John A. Katzenellenbogen, Barry Alan Siegel, Kyuwan Lee, Jaffer A. Ajani, Norman C. Estes, Daniel G. Haller, Jack A. Roth and Walter Kocha. Their work appears in journals such as Journal of Clinical Oncology, Journal of the National Comprehensive Cancer Network, Cancer, The Oncologist and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.